| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Prevention of type 1A diabetes: update. | Isr Med Assoc J | 2004 | 1.38 |
| 2 | Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. | Proc Natl Acad Sci U S A | 2012 | 1.14 |
| 3 | Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. | Cell Transplant | 2012 | 1.03 |
| 4 | TH1/TH2 cytokine secretion of first degree relatives of T1DM patients. | Cytokine | 2005 | 0.83 |
| 5 | Sensitivity of HaCat keratinocytes to diabetogenic toxins. | Biochem Pharmacol | 2002 | 0.83 |
| 6 | The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage. | J Pharmacol Exp Ther | 2010 | 0.79 |
| 7 | Induction of beta-cell resistance to hypoxia and technologies for oxygen delivery to transplanted pancreatic islets. | Diabetes Metab Res Rev | 2012 | 0.79 |
| 8 | Islet transplantation in a subarachnoid cavity surrounding olfactory bulb of diabetic rats. | Transplantation | 2013 | 0.75 |